ReaGenics
The startup produces cannabinoid profiles using a patented plant cell bioreactor technology that enables the mass-scale multiplication of specific molecules without the need for large-scale cultivation of cannabis plants. This approach provides clients with consistent, controlled, and patentable formulations of pharma-grade, botanically-derived compounds.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$6.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup produces cannabinoid profiles using a patented plant cell bioreactor technology that enables the mass-scale multiplication of specific molecules without the need for large-scale cultivation of cannabis plants. This approach provides clients with consistent, controlled, and patentable formulations of pharma-grade, botanically-derived compounds.